Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
17.57x3.34x-4.92x4.34x11.54x12.26x-.--% 1.97TCr
50.93x8.28x2.02x12.4x44.72x46x-.--% 5.57TCr
-31.88x63.71x-2.99x80.89x-35.76x-35.22x-.--% 4.19TCr
16.2x3.82x0.22x5.68x12.87x14.88x1.75% 3.86TCr
-25.86x1.12x-1.53x3.49x-10.23x-7.79x-.--% 2.34TCr
27.79x2.57x0.73x5.44x15.09x18.79x-.--% 1.74TCr
-514.7x14.1x8.12x29.79x702.43x-599.11x-.--% 1.47TCr
-14.46x - -0.05x181.97x-28.37x-14.13x-.--% 1.44TCr
-190.92x23.07x-2.34x47.06x-187.75x-162.6x-.--% 1.34TCr
-57.95x21.39x1.05x13.02x-55.19x-49.76x-.--% 1.29TCr
16.55x4.34x0.37x4.61x11.45x12.87x-.--% 1.14TCr
-20.77x17.24x-0x20.95x-32.47x-20.38x-.--% 931.65Cr
-18.84x8.94x-0.41x - -19.41x-18.75x-.--% 837.69Cr
-10.15x-15.49x-0.5x88.6x-12.43x-12.17x-.--% 784.08Cr
-16.44x12.84x-0.22x125.54x-19.1x-18.6x-.--% 730.16Cr
790.41x41.67x-6.56x95.24x856.76x1108.29x - 701.43Cr
Average 1.09x 14.06x -0.44x 47.93x 78.38x 17.16x 0.12% 1.9TCr
Weighted average by Cap. -11.72x 16.47x -0.24x 37.09x 45.81x -8.09x 0.23%
Bio Therapeutic Drugs